l carnitine in renal failure Summary of studies on oral L-carnitine treatment end-stage The effects of L-carnitine on

Evaluation of mice motor and non-motor behavior were based on surrogate markers for symptoms seen in PD patients 1

Patient preference for oncedaily vs flexible dosing

Category fluency did not improve from rest to exercise in either the placebo (8.86 9.80%, p = 0.756) or huperzine A trial (0.53 8.00%, p = 0.609)

/ , L-, ( , ), ( ), ( , K, , ),

There are, so far, two primary FDA-approved uses for L-Carnitine supplements

Synthesis of carnitine occurs in the kidney, liver and brain, and it is transported to other tissues in the circulation before it is taken up by tissues by carnitine transporters at the plasma membrane that are tissue-specific